CARLAT WEBINAR Ketamine and the Evolving Psychopharmacologic Pipeline for Depression December 8, 2023 Robert C. Meisner, MD 0.50 CME Credits. Robert Meisner, MD, explores the latest developments in psychiatric treatment with ketamine and esketamine, including their differences and emerging insights for clinicians. Read More
General PsychiatryKarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change EverythingRead More
Psychology and Social WorkCBT-I: The First-Line Treatment for Chronic Insomnia with Dr. Donn Posner (Part 1 of 2) Dr. Donn Posner is a leading expert in cognitive behavioral therapy for insomnia (CBT-I) and one of the field's most active educators.Listen now
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
